Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Home›Research›Companies

Companies

Loading
Home›
Research›
Companies›
FlexDex
AddedFeb 15, 2024
UpdatedJun 18, 2026
FlexDex

FlexDex

Public

FlexDex: Transforming surgeon's movements into high-dexterity, minimally invasive surgical procedures.

HQ
Brighton, MI, US
Founded
2010
Overview
Compare
Fundraising
Employees
Website

FlexDex develops advanced medical devices for minimally invasive surgery, focusing on enhancing surgical precision and dexterity. Their flagship product, the AXIUS™ 8mm Needle Driver, translates a surgeon's hand, wrist, and arm movements into corresponding actions inside the patient's body. This FDA-registered device offers robotic-like suturing capabilities in a hand-held mechanical design, providing enhanced dexterity and precision while maintaining tactile feedback.

The company's technology aims to improve surgical outcomes by offering better ergonomics than traditional laparoscopy, with a minimal learning curve for surgeons. FlexDex's reusable devices integrate easily into existing laparoscopic workflows, potentially reducing costs over multiple procedures. Their innovative approach to surgical instrumentation seeks to bridge the gap between traditional laparoscopic tools and more complex robotic systems.

FlexDex - Similar Companies

Agile EndoSurgery logo

Agile EndoSurgery

Surgimatix logo

Surgimatix

surgimatix.com

EndoQuest Robotics logo

EndoQuest Robotics

NovaTract Surgical logo

NovaTract Surgical

novatract.com

Virtuoso Surgical logo

Virtuoso Surgical

Minimally Invasive Devices logo

Minimally Invasive Devices

Intuitive Surgical logo

Intuitive Surgical

intuitive.com

Xact Medical logo

Xact Medical

xactmedical.com

Intuitive Surgical logo

Intuitive Surgical

XSurgical Robotics logo

XSurgical Robotics

Virtual Incision logo

Virtual Incision

Origami Surgical logo

Origami Surgical

Cambridge Endoscopic Devices logo

Cambridge Endoscopic Devices

Revolve Surgical logo

Revolve Surgical

Surgrx logo

Surgrx

FlexDex - Quick Facts

Who are FlexDex's competitors?

Companies similar to FlexDex include Agile EndoSurgery, Surgimatix, EndoQuest Robotics and NovaTract Surgical.

When was FlexDex founded?

FlexDex was founded in 2010.

Where is FlexDex's headquarters located?

FlexDex's headquarters is located in Brighton, MI, US.

When was FlexDex's last funding round?

FlexDex's most recent funding round was for $13M (USD) in August 2021.

How much has FlexDex raised to-date?

As of Aug 24, 2021, FlexDex has raised a total of $37.8M (USD).

How many employees does FlexDex have?

FlexDex has 30 employees as of Feb 5, 2024.

FlexDex - Classification

Industry
  • Hardware
Ownership
  • Public
Technology
  • Robotics
Geographic Exposure
  • Global
Revenue
  • Recurring
Customer
  • Enterprise
Main Product
  • Medical Devices
Tags
  • Healthtech
NAICS
  • 320000Manufacturing
  • 325400Pharmaceutical and Medicine Manufacturing
  • 325000Chemical Manufacturing
  • 325410Pharmaceutical and Medicine Manufacturing
SIC
  • 5000Wholesale Trade-durable Goods
  • 5040Professional And Commercial Equipment And Supplies
  • 5047Medical, Dental, And Hospital Equipment And Supplies
Show 7 more industry codes
NAICS
  • 330000Manufacturing
  • 620000Health Care and Social Assistance
  • 623000Nursing and Residential Care Facilities
SIC
  • 3900Miscellaneous Manufacturing Industries
  • 8000Health Services
  • 8040Offices And Clinics Of Other Health Practitioners
  • 8049Offices And Clinics Of Health Practitioners, Not Elsewhere Classified